{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:32:08Z","timestamp":1772728328738,"version":"3.50.1"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8,1]]},"DOI":"10.2146\/ajhp090069","type":"journal-article","created":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T22:02:59Z","timestamp":1279836179000},"page":"1260-1264","source":"Crossref","is-referenced-by-count":13,"title":["Decrease in serum valproic acid levels during treatment with ertapenem"],"prefix":"10.1093","volume":"67","author":[{"given":"Fen-Fen","family":"Liao","sequence":"first","affiliation":[{"name":"Department of Pharmacy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaw-Bin","family":"Huang","sequence":"additional","affiliation":[{"name":"Graduate Institute of Clinical Pharmacy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Yu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041104274547200_b1-0671260","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1528-1157.1982.tb05085.x","article-title":"Sodium valproate: monotherapy and polytherapy","volume":"23","author":"Covanis","year":"1982","journal-title":"Epilepsia"},{"key":"key\n\t\t\t\t2019041104274547200_b2-0671260","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2125.2005.02529.x","article-title":"Clinically relevant drug interactions with antiepileptic drugs","volume":"61","author":"Perucca","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019041104274547200_b3-0671260","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1345\/aph.1K079","article-title":"Interaction between valproate and meropenem: a retrospective study","volume":"41","author":"Spriet","year":"2007","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t2019041104274547200_b4-0671260","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1345\/aph.1E358","article-title":"Acute seizures due to a probable interaction between valproic acid and meropenem","volume":"39","author":"Coves-Orts","year":"2005","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t2019041104274547200_b5-0671260","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jac\/39.2.295","article-title":"Decrease in serum levels of valproic acid during treatment with a new carbapenem, panipenem\/betamipron","volume":"39","author":"Nagai","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019041104274547200_b6-0671260","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1592\/phco.27.8.1202","article-title":"Acute seizures in a patient receiving divalproex sodium after starting ertapenem therapy","volume":"27","author":"Lunde","year":"2007","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t2019041104274547200_b7-0671260","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1023\/A:1006990925122","article-title":"Metabolism and excretion of mood stabilizers and new anticonvulsants","volume":"19","author":"Ketter","year":"1999","journal-title":"Cell Mol Neurobiol"},{"key":"key\n\t\t\t\t2019041104274547200_b8-0671260","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00003088-198815060-00002","article-title":"Clinical pharmacokinetics of valproic acid","volume":"15","author":"Zaccara","year":"1988","journal-title":"Clin Pharmacokinet"},{"issue":"suppl 2","key":"key\n\t\t\t\t2019041104274547200_b9-0671260","first-page":"ii11","article-title":"In vitro activity of ertapenem: review of recent studies","volume":"53","author":"Wexler","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"suppl 2","key":"key\n\t\t\t\t2019041104274547200_b10-0671260","first-page":"ii23","article-title":"Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians","volume":"53","author":"Nix","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019041104274547200_b11-0671260","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t2019041104274547200_b12-0671260","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1345\/aph.1H423","article-title":"Proposal for a new tool to evaluate drug interaction cases","volume":"41","author":"Horn","year":"2007","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t2019041104274547200_b13-0671260","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1128\/AAC.42.12.3136","article-title":"Possible mechanism by which the carbapenem antibiotic panipenem decreases the concentration of valproic acid in plasma in rats","volume":"42","author":"Kojima","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019041104274547200_b14-0671260","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0022-3565(25)31879-3","article-title":"Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect","volume":"211","author":"Dickinson","year":"1979","journal-title":"J Pharmacol Exp"},{"key":"key\n\t\t\t\t2019041104274547200_b15-0671260","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0022-3565(25)32016-1","article-title":"Nonlinear elimination and choleretic effect of valproic acid in the monkey","volume":"213","author":"Dickinson","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t2019041104274547200_b16-0671260","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0090-9556(24)15311-1","article-title":"Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats","volume":"27","author":"Yamamura","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"key\n\t\t\t\t2019041104274547200_b17-0671260","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/S0090-9556(24)13678-1","article-title":"Panipenem, a carbapenem antibiotic, increases the level of hepatic UDP-glucuronic acid in rats","volume":"28","author":"Yamamura","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"key\n\t\t\t\t2019041104274547200_b18-0671260","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1124\/dmd.104.000661","article-title":"Mechanism of the drug interaction between valproic acid and carbapenem antibiotics in monkeys and rats","volume":"32","author":"Nakajima","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"key\n\t\t\t\t2019041104274547200_b19-0671260","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1211\/0022357011776171","article-title":"Inhibition by carbapenem antibiotic imipenem of intestinal absorption of valproic acid in rats","volume":"53","author":"Torii","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"key\n\t\t\t\t2019041104274547200_b20-0671260","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0378-5173(01)00916-4","article-title":"Carbapenem antibiotics inhibit valproic acid transport in Caco-2 cell monolayers","volume":"233","author":"Torii","year":"2002","journal-title":"Int J Pharm"},{"key":"key\n\t\t\t\t2019041104274547200_b21-0671260","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1023\/A:1013046229699","article-title":"Effect of meropenem on disposition kinetics of valproate and its metabolites in rabbit","volume":"18","author":"Yokogawa","year":"2001","journal-title":"Pharm Res"},{"key":"key\n\t\t\t\t2019041104274547200_b22-0671260","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1248\/jhs.53.302","article-title":"In vitro activation of valproate glucuronidation by carbapenem antibiotics","volume":"53","author":"Mori","year":"2007","journal-title":"J Health Sci"},{"key":"key\n\t\t\t\t2019041104274547200_b23-0671260","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/jps.20338","article-title":"Increased erythrocyte distribution of valproic acid in pharmacokinetic interaction with carbapenem antibiotics in rat and human","volume":"94","author":"Omoda","year":"2005","journal-title":"J Pharm Sci"},{"key":"key\n\t\t\t\t2019041104274547200_b24-0671260","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.eplepsyres.2006.05.016","article-title":"Interaction of valproic acid and carbapenem antibiotics with multidrug resistance-associated proteins in rat erythrocyte membranes","volume":"71","author":"Ogawa","year":"2006","journal-title":"Epilepsy Res"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/67\/15\/1260\/28344621\/ajhp1260.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T07:32:20Z","timestamp":1740295940000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/67\/15\/1260\/5130832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,1]]},"references-count":24,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2010,8,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp090069","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,8,1]]},"published":{"date-parts":[[2010,8,1]]}}}